Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

The Role of Medical Device Consulting in Successful Product Launches

Mar 20, 2025

Understanding the Importance of Medical Device Consulting

In the competitive landscape of medical device development, launching a successful product requires more than just an innovative idea. It demands a comprehensive strategy that spans regulatory compliance, market analysis, and effective commercialization. This is where medical device consulting plays a pivotal role, guiding companies through the complex journey from concept to market.

Medical device consultants bring a wealth of expertise and insights to the table. Their role is critical in navigating the intricate regulatory requirements that vary across regions. By ensuring compliance with standards like ISO 13485 and FDA regulations, consultants help companies avoid costly delays and rejections.

medical consultant

Regulatory Compliance and Risk Management

One of the most significant contributions of medical device consulting is in the domain of regulatory compliance. Consultants are adept at interpreting and implementing the myriad of regulations that govern medical devices. They assist in preparing necessary documentation, conducting risk assessments, and ensuring that all safety standards are met.

Effective risk management is another area where consultants provide invaluable support. They help identify potential risks early in the development process and devise strategies to mitigate them. This proactive approach not only enhances product safety but also builds trust with regulatory bodies and end-users.

The Role in Market Analysis and Strategy

Beyond regulatory aspects, medical device consultants play a crucial role in market analysis. They conduct thorough research to understand market needs, competitive landscapes, and emerging trends. This information is vital for developing a product that not only meets regulatory standards but also addresses the needs of healthcare professionals and patients.

market research

Consultants also aid in crafting effective market entry strategies. They provide insights into pricing models, distribution channels, and promotional tactics that can significantly impact the product's success. With their guidance, companies can position their devices optimally to gain a competitive edge.

Streamlining Product Development

Medical device consulting firms often offer services that streamline the product development process. They help companies design efficient workflows and project timelines, ensuring that development stages are completed on schedule. This strategic planning reduces time-to-market, which is crucial in the fast-paced medical device industry.

Additionally, consultants facilitate collaboration between various stakeholders involved in product development. By fostering communication among engineers, designers, regulatory experts, and marketers, they ensure that all aspects of the product meet quality standards and market demands.

product development

Enhancing Commercialization Success

The final step in a successful medical device launch is commercialization. Consultants assist in devising robust marketing plans that resonate with target audiences. They leverage their industry connections and knowledge to create impactful sales strategies and educational programs for healthcare professionals.

Moreover, post-launch support is an essential service provided by consulting firms. They help monitor product performance, gather user feedback, and implement improvements as needed. This continuous support ensures that the product remains competitive and compliant with any evolving regulations.

In conclusion, medical device consulting is a multifaceted service that plays a critical role in the successful launch of medical devices. By providing expertise in regulatory compliance, market strategy, product development, and commercialization, consultants enable companies to navigate challenges and seize opportunities in this dynamic industry.